Related references
Note: Only part of the references are listed.The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions
Mina Kabiri et al.
ANNALS OF INTERNAL MEDICINE (2014)
Accelerating Drug Development Through Collaboration:The Hepatitis C Drug Development Advisory Group
C. Hutchison et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Accelerated Access to Innovative Medicines for Patients in Need
L. G. Baird et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Synthesis and functional characterization of a fluorescent peptide probe for non invasive imaging of collagen in live tissues
Ushasri Chilakamarthi et al.
EXPERIMENTAL CELL RESEARCH (2014)
Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
Shuhei Yoshida et al.
GASTROENTEROLOGY (2014)
Integrins, Myofibroblasts, and Organ Fibrosis
Michel Fausther et al.
HEPATOLOGY (2014)
Mesodermal Mesenchymal Cells Give Rise to Myofibroblasts, but Not Epithelial Cells, in Mouse Liver Injury
Ingrid Lua et al.
HEPATOLOGY (2014)
Pharmacological Inhibition of the Chemokine C-C Motif Chemokine Ligand 2 (Monocyte Chemoattractant Protein 1) Accelerates Liver Fibrosis Regression by Suppressing Ly-6C+ Macrophage Infiltration in Mice
Christer Baeck et al.
HEPATOLOGY (2014)
The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis
Michael H. Miller et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Role of magnetic resonance elastography in compensated and decompensated liver disease
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2014)
Origin of myofibroblasts in the fibrotic liver in mice
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The types of hepatic rnyofibroblasts contributing to liver fibrosis of different etiologies
Jun Xu et al.
FRONTIERS IN PHARMACOLOGY (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
TGF-beta signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
Rohan Samarakoon et al.
CELLULAR SIGNALLING (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Elastin-Based Molecular MRI of Liver Fibrosis
Josef Ehling et al.
HEPATOLOGY (2013)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular MRI of collagen to diagnose and stage liver fibrosis
Bryan C. Fuchs et al.
JOURNAL OF HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
Neil C. Henderson et al.
NATURE MEDICINE (2013)
LIVER FIBROSIS IN 2012 Convergent pathways that cause hepatic fibrosis in NASH
Scott L. Friedman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The Gordian Knot of dysbiosis, obesity and NAFLD
Wajahat Z. Mehal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
Mechanisms of Disease Progression in NASH: New Paradigms
Brittany N. Bohinc et al.
CLINICS IN LIVER DISEASE (2012)
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
Joy X. Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Laurent Castera
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
Cynthia D. Guy et al.
HEPATOLOGY (2012)
Quantitative histological-hemodynamic correlations in cirrhosis
Supatsri Sethasine et al.
HEPATOLOGY (2012)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
Roberta D'Ambrosio et al.
HEPATOLOGY (2012)
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial
Gregory T. Everson et al.
HEPATOLOGY (2012)
Anti-fibrotic therapy: Lost in translation?
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2012)
Functional aspects on the pathophysiology of portal hypertension in cirrhosis
Juan-Carlos Garcia-Pagan et al.
JOURNAL OF HEPATOLOGY (2012)
Microparticles: Modulators and biomarkers of liver disease
Miroslaw Kornek et al.
JOURNAL OF HEPATOLOGY (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EFFECTS OF ACOUSTIC RADIATION FORCE ON THE BINDING EFFICIENCY OF BR55, A VEGFR2-SPECIFIC ULTRASOUND CONTRAST AGENT
Peter J. A. Frinking et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2012)
Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase
Victor J. Thannickal
FIBROGENESIS & TISSUE REPAIR (2012)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Liver stiffness diminishes with antiviral response in chronic hepatitis C
C. Hezode et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
Abby L. Olsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Biomarkers of Liver Fibrosis: What Lies Beneath the Receiver Operating Characteristic Curve?
Indra Neil Guha et al.
HEPATOLOGY (2011)
The Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NOX) Homologues NOX1 and NOX2/gp91phox Mediate Hepatic Fibrosis in Mice
Yong-Han Paik et al.
HEPATOLOGY (2011)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Scraping fibrosis
Wajahat Z. Mehal et al.
NATURE MEDICINE (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Endothelin and hepatic wound healing
Al-karim Khimji et al.
PHARMACOLOGICAL RESEARCH (2011)
Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man
J. M. Schattenberg et al.
DIGESTIVE DISEASES (2010)
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo
Joy X. Jiang et al.
GASTROENTEROLOGY (2010)
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
Robert J. Fontana et al.
GUT (2010)
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Julie Parkes et al.
GUT (2010)
Portal Fibroblasts: Underappreciated Mediators of Biliary Fibrosis
Jonathan A. Dranoff et al.
HEPATOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
Rajiv Mahajan et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2010)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies
Yury Popov et al.
HEPATOLOGY (2009)
Exceeding the limits of liver histology markers
Shruti H. Melita et al.
JOURNAL OF HEPATOLOGY (2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux et al.
PLOS ONE (2009)
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update
T. Poynard et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2008)
Inhibition of integrin αvβ6 on cholangiocytes blocks transforming growth factor-β activation and retards biliary fibrosis progression
Eleonora Patsenker et al.
GASTROENTEROLOGY (2008)
Prediction of Clinical Outcomes in Primary Biliary Cirrhosis by Serum Enhanced Liver Fibrosis Assay
Marlyn J. Mayo et al.
HEPATOLOGY (2008)
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
Paul Cales et al.
LIVER INTERNATIONAL (2008)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Integrin-mediated activation of latent transforming growth factor beta
D Sheppard
CANCER AND METASTASIS REVIEWS (2005)
Share Paper
